Blackstone Inc’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8,761
Closed -$95K 611
2021
Q3
$95K Buy
+8,761
New +$79.7K ﹤0.01% 542
2021
Q1
Sell
-2,567,445
Closed -$10.1M 525
2020
Q4
$10.1M Hold
2,567,445
0.04% 109
2020
Q3
$6.8M Hold
2,567,445
0.03% 110
2020
Q2
$17M Hold
2,567,445
0.07% 60
2020
Q1
$14.9M Hold
2,567,445
0.11% 38
2019
Q4
$23M Hold
2,567,445
0.15% 19
2019
Q3
$22.2M Hold
2,567,445
0.13% 22
2019
Q2
$28.6M Hold
2,567,445
0.15% 23
2019
Q1
$34.1M Hold
2,567,445
0.17% 23
2018
Q4
$39.7M Buy
+2,567,445
New +$49M 0.22% 19

Other funds holding GRTS

Blackstone Inc's GRTS Position: Q4 2021 in Review

Blackstone Inc sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2021, closing a stake of 8,761 shares — an estimated $95K sold.

Blackstone Inc first reported a position in GRTS in Q4 2018 and held it in 10 quarters. The position peaked at $39.7M in Q4 2018. 115 funds tracked by Wall St. Rank hold GRTS as of Q4 2021.

  • Blackstone Inc reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Blackstone Inc sold 8,761 Gritstone bio, Inc. Common Stock shares in Q4 2021, an estimated $95K.
  • Blackstone Inc first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 10 quarters.
  • Blackstone Inc's Gritstone bio, Inc. Common Stock position peaked at $39.7M in Q4 2018.
  • 115 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2021.

Based on Blackstone Inc's 13F filing for Q4 2021, filed 14 Feb 2022.